Daily Sepsis Research Analysis
Today's most impactful sepsis research spans mechanistic biology, diagnostics, and translational tools. A preclinical study identifies Nur77 as a regulator of ER-phagy that protects Paneth cells and mitigates gut-driven inflammation in sepsis, a systematic review challenges multisite blood culture dogma favoring single-site, adequate-volume sampling, and a two-photon iridium probe enables mitochondrial nitroreductase imaging to monitor sepsis-induced lung injury and treatment response.
Summary
Today's most impactful sepsis research spans mechanistic biology, diagnostics, and translational tools. A preclinical study identifies Nur77 as a regulator of ER-phagy that protects Paneth cells and mitigates gut-driven inflammation in sepsis, a systematic review challenges multisite blood culture dogma favoring single-site, adequate-volume sampling, and a two-photon iridium probe enables mitochondrial nitroreductase imaging to monitor sepsis-induced lung injury and treatment response.
Research Themes
- Intestinal barrier protection and ER-phagy mechanisms in sepsis
- Optimizing blood culture strategies for sepsis diagnosis
- Advanced imaging probes for sepsis-induced organ injury
Selected Articles
1. Nur77 attenuates Paneth cell necroptosis-induced intestinal inflammation through regulating endoplasmic reticulum homeostasis in sepsis.
Using systemic and Paneth cell-specific Nur77 knockout mice, the authors show that Nur77 prevents Paneth cell necroptosis in sepsis by promoting ER-phagy via a Nur77–PKCα–AMFR–FAM134B axis. Nur77 deficiency worsened intestinal inflammation and altered ileal microbiota, while pharmacologic activation of Nur77 (BTP, Csn-B) restored Paneth cell homeostasis and reduced inflammation.
Impact: This study uncovers a druggable ER-phagy pathway controlling Paneth cell survival in sepsis and demonstrates therapeutic rescue with Nur77 agonists, advancing mechanistic understanding and target identification for gut-derived sepsis pathology.
Clinical Implications: While preclinical, the Nur77–ER-phagy axis suggests a strategy to preserve the intestinal barrier in sepsis, potentially reducing bacterial translocation and systemic inflammation. Nur77 agonists merit translational evaluation as adjuvants to standard sepsis care.
Key Findings
- Nur77 deficiency (systemic or Paneth cell-specific) exacerbated intestinal inflammation by increasing Paneth cell necroptosis in sepsis models.
- LPS induced Nur77–PKCα interaction and ER translocation, promoting AMFR phosphorylation, FAM134B ubiquitination, and ER-phagy.
- Nur77 deficiency altered ileal microbiota without disrupting the intestinal stem cell niche after LPS challenge.
- Nur77 agonists (BTP, Csn-B) reduced intestinal inflammation and restored Paneth cell homeostasis in septic mice.
Methodological Strengths
- Use of both systemic and Paneth cell-specific knockout mouse models with multimodal cell death assessments (TUNEL, IF, TEM).
- Mechanistic validation with protein interaction assays and structure prediction linking Nur77 to ER-phagy effectors.
Limitations
- Preclinical murine models; human validation and clinical endpoints (e.g., mortality, infection control) were not assessed.
- Predominant reliance on LPS challenge limits generalizability across diverse sepsis etiologies.
Future Directions: Translate Nur77 agonists into sepsis models with polymicrobial infection, evaluate barrier function and survival, and pursue biomarker development for ER-phagy activity in human sepsis.
INTRODUCTION: Sepsis, a systemic inflammatory syndrome, is frequently associated with intestinal dysfunction, which in turn exacerbates disease severity. Intestinal epithelial Paneth cells exhibit increased susceptibility to necroptosis upon inflammatory stimulation. Nuclear receptor Nur77 has been implicated in multiple programmed cell death pathways. However, the precise role of Nur77 in regulating Paneth cell necroptosis during sepsis remains unclear. OBJECTIVES: This study elucidates the role and underlying molecular mechanisms of nuclear receptor Nur77 in regulating Paneth cell necroptosis during sepsis. METHODS: We employed both systemic and Paneth cell-specific Nur77 knockout mouse models. Paneth cell necroptosis was assessed using TUNEL staining, immunofluorescence, and transmission electron microscopy. Endoplasmic reticulum (ER) homeostasis was evaluated based on ultrastructural integrity, ER-phagy, and ER stress. Protein modification and protein-protein interaction were validated by structure prediction and immunoprecipitation. RESULTS: Systemic or Paneth cell-specific Nur77 knockout exacerbated intestinal inflammation by enhancing Paneth cell necroptosis during sepsis. Nur77 deficiency in Paneth cells altered ileal microbiota rather than intestinal stem cell niche after LPS challenge. Nur77 deficiency-induced Paneth cell necroptosis was attributed to impaired ER homeostasis caused by defective ER-phagy. Mechanistically, LPS induced Nur77-PKCα interaction and their subsequent translocation to the ER, which promoted AMFR phosphorylation, FAM134B ubiquitination and subsequently ER-phagy. Treatment with Nur77 agonists (BTP and Csn-B) alleviated intestinal inflammation and restored Paneth cell homeostasis in sepsis mice. CONCLUSION: This study demonstrates that Paneth cell necroptosis plays a critical role in intestinal inflammation. Our work also identifies Nur77 as a potential therapeutic target to protect Paneth cells and maintain intestinal homeostasis during sepsis, pointing out the therapeutic potential of Nur77 agonist in sepsis.
2. Single-site sampling strategy versus multisite sampling strategy in blood culture collection within the hospital setting: A systematic review.
Across 7 studies (18,901 participants), single-site blood culture sampling with adequate volume achieved similar or superior bacteremia detection compared with multisite sampling, without higher contamination. Evidence heterogeneity exists, but the findings challenge the need for routine multisite draws in hospital sepsis evaluations.
Impact: By prioritizing blood volume over multiple puncture sites, this review supports simpler, faster, and potentially safer blood culture workflows, with implications for sepsis diagnostics and antimicrobial stewardship.
Clinical Implications: Hospitals could design protocols emphasizing adequate-volume single-site blood cultures to expedite sampling, reduce patient discomfort and contamination, and maintain diagnostic yield. Local validation and quality monitoring remain essential.
Key Findings
- Five of seven studies reported improved pathogen detection and lower contamination when increasing blood volume using single-site sampling.
- Across 18,901 participants and 24,955 cultures, single-site strategies performed similarly or better than multisite strategies for bacteremia detection.
- Study quality varied with potential biases and heterogeneity in collection methods.
Methodological Strengths
- Comprehensive multi-database search strategy and explicit comparison of SSS versus MSS.
- Large aggregated sample size increasing precision of estimates.
Limitations
- Heterogeneity in sampling techniques and study designs; overall variable quality with potential bias.
- Lack of randomized trials and limited data on time-to-antibiotics or patient-centered outcomes.
Future Directions: Prospective, randomized or high-quality pragmatic studies comparing SSS and MSS with standardized volumes and protocols, incorporating time-to-antibiotics, contamination monitoring, and clinical outcomes.
BACKGROUND: Many global infectious disease and sepsis guidelines suggest a multisite sampling (MSS) strategy of blood cultures to diagnose bloodstream infections, however, single-site sampling (SSS) may be a viable alternative. This systematic review aims to identify the current state of literature comparing SSS to MSS. METHODS: MEDLINE, CINAHL, Pubmed, Web of Science, Scopus, and Google Scholar were searched from inception to August 2023. Studies comparing SSS and MSS in hospital settings among adult patients were included. Key outcomes being compared were bacteremia detection, contamination rates, and volume of sample collected. RESULTS: Seven studies met the inclusion criteria and were selected, with a total of 18,901 participants and 24,955 blood culture samples. Despite differences in collection methods, 5 out of 7 studies highlighted that increased blood volume using the SSS technique improves pathogen detection and lowers contamination rates. The studies evaluated were of variable quality with potential bias. CONCLUSIONS: This systematic review demonstrates that the SSS technique for blood culture collection provides similar, if not improved, rates of bacteremia detection without increased contamination. We recommend that the above evidence is considered in future guideline publications.
3. Novel cyclometalated iridium(III) complex-based two-photon probe for visualizing mitochondrial nitroreductase and assessing treatment responses in sepsis-induced lung injury.
The authors designed Cym-Ir-NTR, a mitochondria-targeted two-photon Ir(III) probe that turns on under NTR-mediated nitro-to-amino reduction, enabling high-sensitivity, selective imaging of mitochondrial NTR. They used it to monitor NTR dynamics during sepsis-induced lung injury and quantify response to PHD inhibitors (DMOG, roxadustat), demonstrating a functional imaging approach for SILI.
Impact: This probe fills a technological gap by quantifying mitochondrial NTR in living systems, enabling real-time assessment of SILI pathophysiology and treatment effects—paving the way for translational imaging biomarkers in sepsis.
Clinical Implications: If translated, mitochondrial NTR imaging could stratify patients with SILI, guide hypoxia-modulating therapies (e.g., PHD inhibitors), and serve as a pharmacodynamic biomarker. Current evidence is preclinical and requires validation in animal models and early-phase human studies.
Key Findings
- Cym-Ir-NTR exhibits low baseline luminescence that markedly increases upon NTR-mediated nitro-to-amino reduction (Cym-Ir-AMN).
- Molecular docking supports efficient catalysis by NTR; the probe shows high sensitivity, selectivity, rapid response, low toxicity, and strong mitochondrial targeting.
- First demonstration of monitoring mitochondrial NTR changes during SILI progression and assessing therapeutic response to PHD inhibitors (DMOG, roxadustat).
Methodological Strengths
- Rational probe design with computational docking and chemical validation of a clear turn-on mechanism.
- Demonstrated biological applicability through live-cell mitochondrial imaging and disease-model response monitoring.
Limitations
- Evidence is preclinical; no data in animal survival or human subjects.
- In vivo quantitative calibration and specificity against other reductases require further study.
Future Directions: Validate probe performance in animal SILI models with standardized imaging endpoints, develop quantitative imaging protocols, and explore translation to human pulmonary imaging.
BACKGROUND: Sepsis-induced lung injury (SILI) is an acute condition characterized by respiratory failure, with lung hypoxia as a prominent feature. Nitroreductase (NTR) is significantly upregulated during SILI, highlighting its potential as a promising biomarker for assessing the severity of SILI and monitoring therapeutic response. Molecular biology studies indicate that mitochondria serve as potential therapeutic targets for SILI. Accurate monitoring of mitochondrial NTR activity in SILI is expected to provide insights into the pathogenesis of the disease and offer valuable guidance for clinical treatment. However, reliable tools for monitoring mitochondrial NTR variations and assessing treatment responses in SILI are still lacking. RESULTS: In this study, a mitochondria-targeting, two-photon Ir(III) complex-based probe, Cym-Ir-NTR, was designed and synthesized for accurate detection of mitochondrial NTR. Cym-Ir-NTR displayed weak luminescence due to the strong electron-withdrawing effect of the nitro group. Under hypoxic conditions, the nitro group is reduced to an amino group, yielding Cym-Ir-AMN, accompanied by significant luminescence enhancement. Molecular docking analysis indicated that Cym-Ir-NTR can be effectively catalyzed by NTR. Cym-Ir-NTR demonstrated high sensitivity, excellent selectivity, and rapid luminescence response to NTR. With its low toxicity and superior mitochondrial-targeting properties, Cym-Ir-NTR enabled successful imaging of mitochondrial NTR in living cells. Notably, leveraging Cym-Ir-NTR as an imaging probe, variations in mitochondrial NTR levels during SILI progression and the therapeutic effect of PHD inhibitors (dimethyloxalylglycine and roxadustat) on SILI were successfully monitored for the first time. SIGNIFICANCE: These findings confirm Cym-Ir-NTR's capability as a robust imaging tool for tracking mitochondrial NTR and evaluating treatment response of SILI to drugs. Additionally, probe Cym-Ir-NTR can be used to reveal the biological roles that mitochondrial NTR plays in SILI and offer valuable guidance for the prevention and treatment of SILI.